These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

439 related articles for article (PubMed ID: 12904992)

  • 1. Age-associated prevalence and risk factors of Lewy body pathology in a general population: the Hisayama study.
    Wakisaka Y; Furuta A; Tanizaki Y; Kiyohara Y; Iida M; Iwaki T
    Acta Neuropathol; 2003 Oct; 106(4):374-82. PubMed ID: 12904992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
    Jellinger KA
    Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical reappraisal of current staging of Lewy-related pathology in human brain.
    Jellinger KA
    Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease.
    Jellinger KA; Attems J
    Acta Neuropathol; 2008 Apr; 115(4):427-36. PubMed ID: 18273624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In dementia with Lewy bodies, Braak stage determines phenotype, not Lewy body distribution.
    Weisman D; Cho M; Taylor C; Adame A; Thal LJ; Hansen LA
    Neurology; 2007 Jul; 69(4):356-9. PubMed ID: 17646627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nigro-striatal and nigro-amygdaloid pathways undergo different degeneration processes in brains of dementia with Lewy bodies.
    Iseki E; Marui W; Yamamoto R; Togo T; Katsuse O; Kato M; Iwatsubo T; Kosaka K; Arai H
    Neurosci Lett; 2005 May 20-27; 380(1-2):161-5. PubMed ID: 15854770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of phosphorylated alpha-synuclein and tau accumulation to Abeta deposition in the cerebral cortex of dementia with Lewy bodies.
    Obi K; Akiyama H; Kondo H; Shimomura Y; Hasegawa M; Iwatsubo T; Mizuno Y; Mochizuki H
    Exp Neurol; 2008 Apr; 210(2):409-20. PubMed ID: 18164295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lewy bodies in the amygdala increase risk for major depression in subjects with Alzheimer disease.
    Lopez OL; Becker JT; Sweet RA; Martin-Sanchez FJ; Hamilton RL
    Neurology; 2006 Aug; 67(4):660-5. PubMed ID: 16924019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathological entity of dementia with Lewy bodies and its differentiation from Alzheimer's disease.
    Marui W; Iseki E; Kato M; Akatsu H; Kosaka K
    Acta Neuropathol; 2004 Aug; 108(2):121-8. PubMed ID: 15235805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusterin/apolipoprotein J is associated with cortical Lewy bodies: immunohistochemical study in cases with alpha-synucleinopathies.
    Sasaki K; Doh-ura K; Wakisaka Y; Iwaki T
    Acta Neuropathol; 2002 Sep; 104(3):225-30. PubMed ID: 12172907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Age-associated prevalence and risk factors of Lewy body pathology in a general population.
    Jellinger KA
    Acta Neuropathol; 2003 Oct; 106(4):383-4. PubMed ID: 12904993
    [No Abstract]   [Full Text] [Related]  

  • 15. How to diagnose dementia with Lewy bodies: state of the art.
    Geser F; Wenning GK; Poewe W; McKeith I
    Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dementia with Lewy bodies.
    McKeith IG; Burn DJ; Ballard CG; Collerton D; Jaros E; Morris CM; McLaren A; Perry EK; Perry R; Piggott MA; O'Brien JT
    Semin Clin Neuropsychiatry; 2003 Jan; 8(1):46-57. PubMed ID: 12567332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropathologic findings of dementia with lewy bodies (DLB) in a population-based Vantaa 85+ study.
    Oinas M; Polvikoski T; Sulkava R; Myllykangas L; Juva K; Notkola IL; Rastas S; Niinistö L; Kalimo H; Paetau A
    J Alzheimers Dis; 2009; 18(3):677-89. PubMed ID: 19625740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of cerebral amyloid deposition and its relevance to clinical phenotype in Lewy body dementia.
    Fujishiro H; Iseki E; Higashi S; Kasanuki K; Murayama N; Togo T; Katsuse O; Uchikado H; Aoki N; Kosaka K; Arai H; Sato K
    Neurosci Lett; 2010 Dec; 486(1):19-23. PubMed ID: 20851165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of alpha-synuclein isoforms in dementia with Lewy bodies.
    Beyer K; Lao JI; Carrato C; Mate JL; López D; Ferrer I; Ariza A
    Neuropathol Appl Neurobiol; 2004 Dec; 30(6):601-7. PubMed ID: 15541000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reappraisal of a consecutive autopsy series of patients with primary degenerative dementia: Lewy-related pathology.
    Oinas M; Sulkava R; Polvikoski T; Kalimo H; Paetau A
    APMIS; 2007 Jul; 115(7):820-7. PubMed ID: 17614849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.